BCL2L11 and neoplasm: Although EBNA3A and EBNA3C are not generally expressed in GC B cells or eBL, their continued expression may not be required in progeny cells for a profound anti-apoptotic effect to be sustained in the developing tumour as the repression of Bim they initiate and/or maintain is epigenetic and therefore heritable.